News

Background Women with pre-eclampsia are at increased risk of later-life cardiovascular disease (CVD). Despite suggestions ...
Background Cancer survivors have an increased risk of heart failure, but this is balanced by the risk of death from other ...
Background Surgical ablation (SA) is a key treatment for atrial fibrillation (AF) patients undergoing heart surgery. However, direct comparisons between SA and non-mitral valve (non-MV) surgery alone ...
In the context of a steadily ageing population, there is a continuous increase in the prevalence and incidence of all primary chronic conditions.1 Among the chronic conditions, heart failure (HF), ...
Prevalence and prognostic implications of the Valve Academic Research Consortium-High Bleeding Risk criteria in patients undergoing transcatheter aortic valve implantation ...
Objective In 2014, the European Society of Cardiology (ESC) recommended the use of a novel risk prediction model (HCM Risk-SCD) to guide use of implantable cardioverter defibrillators (ICD) for the ...
OBJECTIVE--To evaluate the incidence, characteristics, and haemodynamic consequences of pericardial effusion after cardiac surgery. DESIGN--Clinical, echocardiographic, and Doppler evaluations before ...
This review gives examples of emerging cardiovascular magnetic resonance (CMR) techniques and applications that have the potential to transition from research to clinical application in the near ...
Background The 2024 European Society of Cardiology (ESC) Guidelines for hypertension introduced the ‘elevated BP’ (eBP) category (120–139/70–89 mm Hg). Individuals with persistent eBP (130–139/80–89 ...
Background Cardiac sarcoidosis (CS) is a chronic inflammatory disease characterised by non-caseating granulomas, while arrhythmogenic cardiomyopathy (ACM) is a genetic condition mainly affecting ...
Cardiovascular alterations are common in patients who had ischaemic stroke, haemorrhagic stroke and other acute brain disorders such as seizures. These cardiac complications are important drivers of ...
Background Delayed heart failure (HF) diagnosis is associated with adverse outcomes and costs of hospitalisation. Whilst previous tools have been developed to predict incident HF, risk of HF incidence ...